Lymphocytes T and B are activated following BNT162b2 administration, and IL-2, IL-4, IL-17, and IL-21 are associated with autoimmune diseases, especially in genetically susceptible individuals [5]. The gene discussed is IL17A; the disease is autoimmune disease.